Join to view full profile
4921 Parkview Pl# DvSt. Louis, MO 63110
Phone+1 800-647-2098
Fax+1 314-362-3192
Dr. Khushman is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Moh'd Khushman is an oncology specialist based in Saint Louis, MO, with a subspecialty in hematologic oncology. He completed his fellowship in hematology and medical oncology at the University of Miami/Jackson Health System, following his residency in internal medicine at Henry Ford Health. He is currently an Associate Professor at Washington University and has held positions as an Assistant and Associate Professor at various institutions, including USA Health and University of Alabama Hospital. His clinical experience encompasses amyloidosis, hematologic oncology, myelodysplasia, myelofibrosis, and multiple myeloma. Dr. Khushman has contributed to several publications, notably on topics such as anal cancer recurrence, gastrointestinal malignancies in older adults, and diagnostic applications in pancreatic adenocarcinoma, with varying levels of citation by other publications.
Education & Training
University of Miami/Jackson Health SystemFellowship, Hematology and Medical Oncology, 2012 - 2015
Henry Ford Health/Henry Ford HospitalResidency, Internal Medicine, 2008 - 2012
University of Jordan Faculty of MedicineClass of 2006
Certifications & Licensure
MO State Medical License 2022 - 2027
AL State Medical License 2015 - 2023
FL State Medical License Active through 2014
MI State Medical License 2008 - 2012
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification ARIA Oncology Information System (for Medical Oncology), Varian Medical Systems, 2016-2017
- CMS Meaningful Use Stage 1 Certification Patient Engagement Portal, Navigating Cancer, Inc., 2016-2017
- CMS Meaningful Use Stage 1 Certification Patient Engagement Portal, Navigating Cancer, Inc., 2016-2017
Publications & Presentations
PubMed
- 4 citationsRNA-seq analysis identifies transcriptomic profiles associated with anal cancer recurrence among people living with HIV.Yuanfan Ye, Kevin J Maroney, Howard W Wiener, Olga A Mamaeva, Anna D Junkins
Annals of Medicine. 2023-12-01 - 2 citationsPerfusion Change of Hepatocellular Carcinoma During Atezolizumab plus Bevacizumab Treatment: A Pilot Study.Ezinwanne Onuoha, Andrew D Smith, Robert Cannon, Moh'd Khushman, Harrison Kim
Journal of Gastrointestinal Cancer. 2023-09-01 - 46 citationsMutational analysis of microsatellite-stable gastrointestinal cancer with high tumour mutational burden: a retrospective cohort study.Jingyuan Wang, Joanne Xiu, Alex Farrell, Yasmine Baca, Hiroyuki Arai
The Lancet. Oncology. 2023-02-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
